Kurt Bock to become chairman of BASF

Successor to Jürgen Hambrecht

The Supervisory Board of BASF has appointed Dr Kurt Bock (51) to succeed Dr Jürgen Hambrecht as chairman of the Board of Executive Directors of BASF.

Dr Martin Brudermüller (49) is to become vice chairman.

Both appointments will take effect after the Annual Meeting on 6 May 2011.

You may also like

Ingredients

Colorcon to purchase BASF’s Kollicoat IR coating system product line

The two firms will also further their cooperation to offer superior functional coatings for pharmaceutical tablets
Design & Build

Siegfried acquires three BASF sites

Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy
Finance

BASF completes €270m sale of custom synthesis business to Siegfried Holding

Deal includes parts of BASF's active pharmaceutical ingredients business
Ingredients

BASF to sell custom synthesis and parts of pharma API business to Siegfried Holding

Ibuprofen, omega-3 fatty acids and polyethylenglycol will remain a key part of BASF’s portfolio
Finance

BASF to cut 260 jobs in Nutrition & Health division by 2015

Aims to strengthen profitability of its Performance Products segment
Ingredients

BASF to purchase US biotechnology firm

Will pay approximately US$57m to strengthen position in enzyme growth market
Ingredients

BASF completes Pronova acquisition

Expanding its omega-3 business in the Nutrition & Health division
Subscribe now